Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Wyatt

Showing results (1-10 of 659) with videos related to

Pageof 66
Sort By:
Archives of General Psychiatry|March 1, 1995
Risks of withdrawing antipsychotic medicationsR J Wyatt
Psychopharmacology Bulletin|July 1, 1976
Biochemistry and schizophrenia (part IV) the neuroleptics--their mechanism of action: a review of the biochemical literatureR J Wyatt
The Australasian Nurses Journal|April 1, 1975
The Adelaide Children's Hospital SchoolR J Wyatt
Schizophrenia Bulletin|January 1, 1997
Research in schizophrenia and the discontinuation of antipsychotic medicationsR J Wyatt
Schizophrenia Research|October 1, 1991
Early intervention with neuroleptics may decrease the long-term morbidity of schizophreniaR J Wyatt
Schizophrenia Bulletin|January 1, 1988
Schizophrenia research in the Intramural Research Program, National Institute of Mental Health: editor's introductionR J Wyatt
Progress in Allergy|January 1, 1986
Deficiencies in regulator proteins. 3. ProperdinR J Wyatt
Psychopharmacology Bulletin|January 1, 1986
The dopamine hypothesis: variations on a theme (II)R J Wyatt
Schizophrenia Bulletin|January 1, 1991
Neuroleptics and the natural course of schizophreniaR J Wyatt
Pediatric Nephrology (Berlin, Germany)|October 1, 1989
Can one predict the prognosis in patients with IgA nephropathy from the analysis of serum complement?R J Wyatt
Pageof 66

Showing results (1-10 of 659) with videos related to

Sort By:
Pageof 66
Archives of General Psychiatry|March 1, 1995
Risks of withdrawing antipsychotic medicationsR J Wyatt
Psychopharmacology Bulletin|July 1, 1976
Biochemistry and schizophrenia (part IV) the neuroleptics--their mechanism of action: a review of the biochemical literatureR J Wyatt
The Australasian Nurses Journal|April 1, 1975
The Adelaide Children's Hospital SchoolR J Wyatt
Schizophrenia Bulletin|January 1, 1997
Research in schizophrenia and the discontinuation of antipsychotic medicationsR J Wyatt
Schizophrenia Research|October 1, 1991
Early intervention with neuroleptics may decrease the long-term morbidity of schizophreniaR J Wyatt
Schizophrenia Bulletin|January 1, 1988
Schizophrenia research in the Intramural Research Program, National Institute of Mental Health: editor's introductionR J Wyatt
Progress in Allergy|January 1, 1986
Deficiencies in regulator proteins. 3. ProperdinR J Wyatt
Psychopharmacology Bulletin|January 1, 1986
The dopamine hypothesis: variations on a theme (II)R J Wyatt
Schizophrenia Bulletin|January 1, 1991
Neuroleptics and the natural course of schizophreniaR J Wyatt
Pediatric Nephrology (Berlin, Germany)|October 1, 1989
Can one predict the prognosis in patients with IgA nephropathy from the analysis of serum complement?R J Wyatt
Pageof 66